1623 Capital’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-5,789
| Closed | -$240K | – | 40 |
|
|
2022
Q3 | $240K | Sell |
5,789
-1,442
| -20% | -$59.8K | 0.15% | 41 |
|
|
2022
Q2 | $431K | Buy |
7,231
+3,187
| +79% | +$190K | 0.27% | 32 |
|
|
2022
Q1 | $294K | Sell |
4,044
-633
| -14% | -$46K | 0.15% | 45 |
|
|
2021
Q4 | $393K | Hold |
4,677
| – | – | 0.15% | 52 |
|
|
2021
Q3 | $422K | Buy |
4,677
+900
| +24% | +$81.2K | 0.16% | 52 |
|
|
2021
Q2 | $360K | Buy |
3,777
+825
| +28% | +$78.6K | 0.14% | 58 |
|
|
2021
Q1 | $336K | Buy |
+2,952
| New | +$336K | 0.14% | 42 |
|